Article
Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Apr 2011
Wursthorn Karsten, Jaroszewicz Jerzy, Zacher Behrend J, Darnedde Martina, Raupach Regina, Mederacke Ingmar, Cornberg Markus, Manns Michael P, Wedemeyer Heiner
Abstract excerpt
BACKGROUND: Hepatitis B surface antigen (HBsAg) clearance during chronic hepatitis B (CHB) infection is associated with improved long-term clinical outcome, so is considered an important therapeutic goal in CHB. Studies have shown that serum HBsAg quantification during, and at end of, treatment may predict long-term HBsAg loss. OBJECTIVES: Performance comparison of the qualitative Elecsys HBsAg II assay using a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
